Inclusion body myositis and HIV infection

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 2 B, 2008, Pages 428-430

  Gomes De Freitas, Marcos R ^a,d   Neves, Marco A O ^a,c   Nascimento, Osvaldo J M ^a   De Mello, Mariana P ^c   Botelho, John P ^c   Chimelli, Leila ^b  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Serra Dos Orgãos University   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; ZIDOVUDINE;

ACHILLES REFLEX; ADULT; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CELL INFILTRATION; DRUG WITHDRAWAL; ELECTROMYOGRAM; FINGER; HAND; HAND MOVEMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCLUSION BODY MYOSITIS; MACROPHAGE; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DISEASE; MUSCLE WEAKNESS; QUADRICEPS FEMORIS MUSCLE; TENDON REFLEX; VIRUS LOAD; WALKING DIFFICULTY; WRIST;

EID: 47749131937     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000300033     Document Type: Article

References (15)

1. Simpson DM, Tagliati M. Neurologic manifestations of HIV infection. Ann Intern Med 1994;121:769-785.
2. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475-495.
3. Wulff EA, Simpson DM. Neuromuscular Complications of the human immunodeficiency virus type 1 infection. Semin Neurol 1999;19:157-164.
4. Dalakas MC, Illa I, Pezeschkpour GH, Laukaitis JP, Cohen B, Griffin JL. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990;322:1098-1105.
5. Roedling S, Pearl D, Manji H, Hanna MG, Holton JL, Miller RF. Unusual muscle disease in HIV infected patients. Sex Transm Infect 2004;80:315-317.
6. Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996;119:1887-1893.
7. Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 2005;32:247-260.
8. Dalakas MC. Sporadic inclusion body myositis: diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437-447.
9. Peng A, Koffman BM, Malley JD, Dalakas MC. Disease progression in sporadic inclusion body myositis: observations in 78 patients. Neurology 2000;55:296-298.
10. Scola RH, Werneck LC, Iwamoto FM, Messias IT, Tsuchiya LV. Análise imunocitoquímica do infiltrado inflamatório na miosite por corpo de inclusão citoplasmática e outras doenças neuromusculares com vacúolos marginados. Arq Neuropsiquiatr 1998;56:388-397.
11. Dalakas MC. Inflammatory, immune and viral aspects of inclusion-body myositis. Neurology 2006;66(Suppl):S33-S38.
12. Ozden S, Cochet M, Mikol J, Teixeira A, Gessain A, Claudine Pique C. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis. J Virol 2004;78:10320-10327.
13. Arnaudo E; Dalakas MC; Shanske S; Moraes CT; Di Mauro S; Schon EA. Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 1991;337:508-510.
14. Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K. Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study. Neurology 1977;48:712-716.
15. Alexanderson H, Lundberg IE. The role of exercise in the rehabilitation of idiopathic inflammatory myopathies. Curr Opin Rheumatol 2005;17:164-171.